Biotech · Private company
Q2 Solutions
Track this companyFree. Adds Q2 Solutions to your Dealase workspace and tells you when its record changes.
Clinical trials91 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials9
- A TQTc Study for OmaveloxolonePHASE1 · COMPLETED · started Jul 11, 2023ClinicalTrials.gov NCT05927649 · fetched Nov 12, 2026
- An Open-label DDI Study of Omaveloxolone in Healthy SubjectsPHASE1 · COMPLETED · started Jul 5, 2023ClinicalTrials.gov NCT05909644 · fetched Nov 12, 2026
- Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic FibrosisPHASE4 · TERMINATED · started Jan 3, 2023ClinicalTrials.gov NCT05561764 · fetched Nov 12, 2026
- Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05188729 · fetched Nov 12, 2026
- ConsideRAte Study - Splenic Stimulation for RANA · RECRUITING · started Oct 19, 2021ClinicalTrials.gov NCT05003310 · fetched Nov 12, 2026
- Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)PHASE2 · COMPLETED · started Jul 27, 2017ClinicalTrials.gov NCT03029247 · fetched Nov 12, 2026
- Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 YearsPHASE3 · COMPLETED · started Jun 22, 2016ClinicalTrials.gov NCT02725593 · fetched Nov 12, 2026
- Maintaining Suppression of Testosterone With Transdermal Estradiol GelPHASE2 · TERMINATED · started Jul 1, 2015ClinicalTrials.gov NCT02349386 · fetched Nov 12, 2026
- Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to ImatinibPHASE2 · COMPLETED · started Sep 12, 2012ClinicalTrials.gov NCT01593254 · fetched Nov 12, 2026